Human primary liver cancer–derived organoid cultures for disease modeling and drug screening L Broutier, G Mastrogiovanni, MMA Verstegen, HE Francies, LM Gavarró, ... Nature medicine 23 (12), 1424-1435, 2017 | 1199 | 2017 |
Long-term expansion, genomic stability and in vivo safety of adult human pancreas organoids N Georgakopoulos, N Prior, B Angres, G Mastrogiovanni, A Cagan, ... BMC developmental biology 20, 1-20, 2020 | 92 | 2020 |
The plastic liver: differentiated cells, stem cells, every cell? CJ Hindley, G Mastrogiovanni, M Huch The Journal of clinical investigation 124 (12), 5099-5102, 2014 | 33 | 2014 |
RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state G Belenguer, G Mastrogiovanni, C Pacini, Z Hall, AM Dowbaj, ... Nature communications 13 (1), 334, 2022 | 29 | 2022 |
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation N Casini, IM Forte, G Mastrogiovanni, F Pentimalli, A Angelucci, ... Oncotarget 6 (14), 12421, 2015 | 26 | 2015 |
Loss of RNF43/ZNRF3 predisposes to Hepatocellular carcinoma by impairing liver regeneration and altering liver fat metabolism G Mastrogiovanni, C Pacini, S Kakava, R Arnes-Benito, CR Bradshaw, ... bioRxiv, 2020.09. 25.313205, 2020 | 6 | 2020 |